Insider Monkey13h agobullish
Is AbbVie Inc. (ABBV) the Best Healthcare Stock to Buy Following the 2026 Democratic Midterm Sweep?News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
104last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Motley Fool6d agobullish
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy for 2027?24/7 Wall St.6d agobullish
2 Safe S&P 500 Healthcare Dividend Stocks Boomers Can Buy and Hold ForeverMT Newswires6d agobullish
RBC Raises Price Target on AbbVie to $330 From $280, Keeps Outperform RatingSimply Wall St.8d agobullish
Is Earnings Beat Altering The Investment Case For AbbVie Stock (ABBV)?Investor's Business Daily40d agobullish
Amazon, Walmart Surplus Auctioneer Climbs Toward A Breakout; Stock Up 45%Motley Fool44d agobullish
AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?Motley Fool45d agobullish
AbbVie vs. Novo Nordisk: Which Drug Giant Stock Is a Better Buy in 2026?Motley Fool45d agobullish
AbbVie vs. Eli Lilly: Which Star Pharma Stock Is a Better Buy in 2026?Insider Monkey47d agobullish
AbbVie (ABBV) Wins EU Approval for Rinvoq in Children. Why a Small Indication Still MattersMotley Fool47d agobullish
AbbVie vs. Pfizer: Which Dividend Stock Is the Better Buy in September?Motley Fool51d agobullish
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?Insider Monkey54d agobullish
Biogen (BIIB) and AbbVie (ABBV) Get Wolfe Upgrades - Which Pharma Stock Has More Upside?Motley Fool55d agobullish
AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?